Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results of a Prospective Dose Escalation Study of Linear Accelerator-Based Virtual Brachytherapy (BOOSTER) for Prostate Cancer; Virtual HDR Brachytherapy for Prostate Cancer.
Eade T, Hruby G, Booth J, Bromley R, Guo L, O'Toole A, Le A, Wu K, Whitaker M, Rasiah K, Chalasani V, Vass J, Kwong C, Atyeo J, Kneebone A. Eade T, et al. Among authors: rasiah k. Adv Radiat Oncol. 2019 Apr 11;4(4):623-630. doi: 10.1016/j.adro.2019.03.015. eCollection 2019 Oct-Dec. Adv Radiat Oncol. 2019. PMID: 31673655 Free PMC article.
Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer.
Amin A, Blazevski A, Thompson J, Scheltema MJ, Hofman MS, Murphy D, Lawrentschuk N, Sathianathen N, Kapoor J, Woo HH, Chalasani V, Rasiah K, van Leeuwen PJ, Tang R, Cusick T, Stricker P, Emmett L. Amin A, et al. Among authors: rasiah k. BJU Int. 2020 Apr;125(4):515-524. doi: 10.1111/bju.14999. Epub 2020 Feb 12. BJU Int. 2020. PMID: 31957122
High-dose rate brachytherapy compared with open radical prostatectomy for the treatment of high-risk prostate cancer: 10 year biochemical freedom from relapse.
Savdie R, Symons J, Spernat D, Yuen C, Pe Benito RA, Haynes AM, Matthews J, Rasiah KK, Jagavkar RS, Yu C, Fogarty G, Kattan MW, Brenner P, Sutherland RL, Stricker PD. Savdie R, et al. Among authors: rasiah kk. BJU Int. 2012 Dec;110 Suppl 4:71-6. doi: 10.1111/j.1464-410X.2012.11480.x. BJU Int. 2012. PMID: 23194129
An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy.
Zhang AY, Chiam K, Haupt Y, Fox S, Birch S, Tilley W, Butler LM, Knudsen K, Comstock C, Rasiah K, Grogan J, Mahon KL, Bianco-Miotto T, Ricciardelli C, Böhm M, Henshall S, Delprado W, Stricker P, Horvath LG, Kench JG. Zhang AY, et al. Among authors: rasiah k. Int J Cancer. 2019 Mar 1;144(5):1151-1159. doi: 10.1002/ijc.31906. Epub 2018 Dec 4. Int J Cancer. 2019. PMID: 30288742 Free PMC article.
High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trial.
Nair-Shalliker V, Smith DP, Gebski V, Patel MI, Frydenberg M, Yaxley JW, Gardiner R, Espinoza D, Kimlin MG, Fenech M, Gillatt D, Woo H, Armstrong BK, Rasiah K, Awad N, Symons J, Gurney H. Nair-Shalliker V, et al. Among authors: rasiah k. BMJ Open. 2021 Mar 2;11(3):e044055. doi: 10.1136/bmjopen-2020-044055. BMJ Open. 2021. PMID: 33653757 Free PMC article.
42 results